Cancer Genomics

Should Women Take the BRACAnalysis Test?

In previous articles, we discussed cancer testing companies such as Raindance Technologies and Sysmex Inostics that can help identify cancer at the earliest stages in order to allow for early treatment. Other companies like Foundation Medicine can interrogate the entire coding sequence of 236 cancer-related genes which will allow a physician to create personalized cancer treatments for […]

MDxHealth Improves Prostate Cancer Biopsies

According to the Prostate Cancer Foundation, prostate cancer is the most common non-skin cancer in America, affecting 1 in 6 men. One new case occurs every 2.3 minutes and a man dies from prostate cancer every 16 minutes. It is estimated that there are more than 2.5 million American men currently living with prostate cancer. One of the […]

Is Guardant Health a Threat to Foundation Medicine?

Sysmex Inostics and Apocell are companies that are looking to provide the ability to test for cancer via a simple blood test which is a promising potential market. Foundation Medicine (NASDAQ:FMI), is looking to address the emerging cancer genomics market by providing a service in which using a biopsy, Foundation can interrogate the entire coding sequence of 236 cancer-related genes. The […]

6 things to like about Foundation Medicine’s Proposed IPO

In an earlier article we discussed the June IPO of Nanostring, an oncology company using microfluidics to test for the risk of recurrence for breast cancer. Another interesting oncology company that filed for IPO on July 29th 2013 is Foundation Medicine. About Foundation Medicine Foundation Medicine is involved in cancer genomics, that is examining the genetic […]